维普中文期刊产品整合服务
64篇 您的检索式:作者名="Kirou"
    题名 作者 年代 出处 被引量
1Activation of the interfbron-α pathway identifies a subgroup of systemic lupus erythematosus pa- tients with distinct serologic features and active disease 显示文摘Kirou KA Lee C Georges S 2005Ar- thritis Rheum2005,52,5:1
2Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo 显示文摘KARIUKI S N KIROU K A MACDERMOTY E J 2009J Immunol2009,182,1:1
3New pieces to the SLE cytokine puzzle显示文摘KIROU AK CEOW MK 1999Clin Immunol1999,91,1:1
4Elevated levels and func- tional capacicy of soluble CIMO ligand in systemic Lupus rythemmosus sora 显示文摘Vakkalanka RK Woo C Kirou KA 1999Arthritis Rheum1999,42,3:1
5Coordinate overexpression of interferon-α-induced genes in systemic lupus erythematosus显示文摘Kirou KA Lee C George S 2004Arthritis Rheum2004,50,:1
6Activation of the interferon-αpathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease显示文摘Kirou KA Lee C George S 2005Arthritis Rheum2005,52,5:1
7Longstanding nonunions of scaphoid fractures with bone loss successful reconstruction with vascularized bone grafts 显示文摘Malizos KN Dailiana ZH Kirou M 2001J Hand Surg [ Br]2001,26,4:1
8Has pain management in cancer patients with bone metastases improved: a seven-year review at an outpatient palliative radiotherapy clinic显示文摘Kirou Mauro AM Hird A Wong J 2009J Pain Symptom Manage2009,37,1:1
9Experimental Echi-nococcus infection in the mouse model: pericystic cellu- lar immunity reaction and effects on the lymphoid or- gans of immunocompetent and thymectomized mice显示文摘Fotiadis C Sergiou C Kirou J 1999In Vivo1999,13,:1
10Activation of the interferon alpha pathway identifies a subgroup of systemic lupus erythe matosus patients with distinct serologic features and active dis case显示文摘Kirou KA Lee C George S 2005Arthritis Rheum2005,52,5:1
11Activation of the interferon-alphapathway identifies a subgroup of systemic lupus erythematosus patientswith distinct serologic features and active disease显示文摘Kirou KA Lee C George S 2005ArthritisRheum2005,52,5:1
12Activation of the in- terferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic fea- tures and active disease 显示文摘Kirou KA Lee C George S 2005Arthritis Rheu2005,52,5:1
13Has pain management in cancer patients with bone metastases improved:a seven-year review at an outpatient palliative radiotherapy clinic显示文摘Kirou AM Hird A Wong J 0,,01:1
14Functional assay of typel interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies 显示文摘Hua J Kirou K Lee C Crow MK 2006Arthritis Rheum2006,54,6:1
15Elevated levels and funcfional capacicy of soluble CD40 ligand in systemic lupus rythematosus sera显示文摘Vakkalanka RK Woo C Kirou KA 1999Arthritis Rheum1999,42,3:1
16Functional assay of type Ⅰ interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies显示文摘 Kirou K Lee C 2006Arthritis Rheum2006,54,:1
17Coordinate overexpression of interferon-a-induced genes in systemic lupus erythematosus显示文摘Kirou KA Lee C George S 2004Arthritis Rheum2004,50,12:1
18Elevated levels and functional capacicy of soluble CD40 ligand in systemic Lupus rythemmosus sera显示文摘Vakkalanka RK Woo C Kirou KA 1999Arthritis Rheum1999,42,3:1
19Microarray analysis of interferon-regulated genes in SLE显示文摘Grow MK Kirou KA Wchlgemuth J 2003Autoimmunity2003,36,:1
20Cutting edge: autoimmune disease riskvariant of STAT4 confers increased sensitivity to IFN-ct in lupus patients in vivo 显示文摘Kariuki SN Kirou KA MacDermott EJ 2009J Immunol2009,182,6:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费